|
CBX6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.436200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.237600E-03 |
| Normal-vs-Stage2 |
5.441900E-02 |
| Normal-vs-Stage3 |
6.979500E-02 |
| Normal-vs-Stage4 |
2.42089999999973E-05 |
| Stage1-vs-Stage2 |
9.723800E-01 |
| Stage1-vs-Stage3 |
9.068600E-01 |
| Stage1-vs-Stage4 |
7.620200E-03 |
| Stage2-vs-Stage3 |
9.511600E-01 |
| Stage2-vs-Stage4 |
6.018000E-02 |
| Stage3-vs-Stage4 |
6.560200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.358160E-02 |
| Normal-vs-AfricanAmerican |
7.375400E-03 |
| Normal-vs-Asian |
3.390500E-04 |
| Caucasian-vs-AfricanAmerican |
3.766200E-01 |
| Caucasian-vs-Asian |
1.337960E-01 |
| AfricanAmerican-vs-Asian |
9.043800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.775530E-03 |
| Normal-vs-Female |
5.244200E-01 |
| Male-vs-Female |
1.034230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.859700E-03 |
| Normal-vs-Extreme_Weight |
6.3894999999925E-05 |
| Normal-vs-Obese |
4.646800E-01 |
| Normal-vs-Extreme_Obese |
3.824400E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.432200E-01 |
| Normal_Weight-vs-Obese |
3.387700E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.359000E-01 |
| Extreme_Weight-vs-Obese |
4.860500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.120800E-01 |
| Obese-vs-Extreme_Obese |
2.881000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.037600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.746100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.697800E-03 |
| Normal-vs-Age(81-100Yrs) |
7.215800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.823600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.555200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.147000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.122800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.155400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.641200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.535930E-02 |
| Normal-VS-Type2 PRCC |
1.078870E-03 |
| Normal-VS-KIRP CIMP |
6.866800E-01 |
| Normal-VS-Unclassified PRCC |
5.192200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.057810E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.304400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.855800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.866400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.791510E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.195600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.75640000000099E-05 |
| Normal-vs-N1 |
9.403600E-02 |
| Normal-vs-N2 |
3.510000E-02 |
| N0-vs-N1 |
2.883800E-01 |
| N0-vs-N2 |
9.948800E-01 |
| N1-vs-N2 |
6.620200E-01 |
|
|
